Boehringer to manufacture Canbridge's ESCC candidate

Canbridge Life Sciences Ltd. (Beijing, China) said Boehringer Ingelheim GmbH (Ingelheim, Germany) will manufacture AV-203 ( CAN-017), Canbridge's candidate to treat esophageal squamous cell cancer, in Shanghai.

Canbridge plans to begin a Phase IIa trial of the candidate in Greater China. A Canbridge spokesperson said Friday she was not certain when the trial is to begin. ...